Breaking News

Tweet TWEET

Get Schooled in Anaphylaxis™ Unveils Interactive Digital Resources to Educate School Communities about Potentially Life

Get Schooled in Anaphylaxis™ Unveils Interactive Digital Resources to Educate
       School Communities about Potentially Life-Threatening Allergies

"Modern Family" Star Julie Bowen Encourages Americans to Visit
Anaphylaxis101.com and Traveling Augmented Reality Exhibit

PR Newswire

BASKING RIDGE, N.J., Oct. 17, 2012

BASKING RIDGE, N.J., Oct. 17, 2012 /PRNewswire/ -- Mylan Specialty L.P. today
announced the launch of a comprehensive, community-inspired resource for
families, school staff and students designed to raise awareness of and
preparedness for life-threatening allergic reactions (anaphylaxis) in the
school setting: www.Anaphylaxis101.com. The enhanced website, which is part
of the Get Schooled in Anaphylaxis™ initiative, now includes a personalized,
virtual tour to access resources provided by leading patient, professional and
advocacy groups. This fall, the educational tools will be brought directly
into communities via an augmented reality exhibit that will travel the country
to drive home the importance of raising awareness about anaphylaxis and being
prepared when anaphylaxis occurs.

To view the multimedia content associated with this release, please click:
http://www.multivu.com/players/English/57462-get-schooled-in-anaphylaxis/.

When logging on to www.Anaphylaxis101.com, visitors will have the option to
enter a virtual experience or find useful resources and materials tailored to
their role in the school community and where they live. The goal is for
students, parents, teachers, administrators, school nurses and other community
members to be able to access information specific to their needs and to learn
how they can contribute to raising anaphylaxis awareness and preparedness in
their hometown.

"We each have a role to play in helping those at risk for life-threatening
allergic reactions avoid their triggers, recognize the signs of a
life-threatening allergic reaction and know what to do when anaphylaxis
occurs," said Emmy award-winning actress and "Modern Family" star Julie Bowen,
who learned of her son's life-threatening allergies only after he experienced
an anaphylactic reaction as a toddler. "I'm asking people to go to
www.Anaphylaxis101.com to become better informed and prepared than I was when
my son experienced anaphylaxis."

To introduce the resources available at www.Anaphylaxis101.com, an interactive
exhibit using animated videos and the latest "augmented reality" technology
will tour the country. At the Get Schooled in Anaphylaxis: An Interactive
Experience exhibit, visitors will activate images on a 120-square-foot mural
through use of the provided tablets or their personal smartphones after
downloading the free Anaphylaxis101 mobile application. They also will
receive educational materials and giveaways, with a special offer for the
first 100 people who visit the exhibit on each stop of the 10-city tour.

"Proper response to anaphylaxis can be a matter of life or death, so knowing
what part we can each play in furthering awareness and preparedness,
particularly in the school community, is critical," said Hemant Sharma, M.D.,
Associate Chief of the Division of Allergy and Immunology at Children's
National Medical Center in Washington, D.C. "Having digital tools centralized
and tailored to support those in the school-based setting is a tremendous
asset that will help educate the public about this significant public health
issue."

About www.Anaphylaxis101.com
The expanded website includes an extensive library of downloadable tools and
resources from leading patient, professional and advocacy organizations to
support personal and school-based anaphylaxis education. The site is designed
to help meet the information needs of the extended community impacted by
potentially life-threatening allergies.

Visitors can access the information through easy-to-use, online toolkits
tailored to the specific needs of:

  oTeachers: Posters, lesson plans, brochures, template forms, checklists,
    guidelines and an "Assembly in a Box" to address school safety in and out
    of the classroom.
  oSchool Administrators: Template forms, letters, a poster, and links to
    resources that can be adapted to improve awareness and preparedness among
    school staff, parents and students.
  oSchool Nurses:  Family allergy and allergic reaction health history form,
    checklists and tip sheets to help ensure nurses know which students might
    be at risk for anaphylaxis.
  oParents:  Medical forms, checklists, guidelines, at-home tools and family
    tips to help educate themselves, loved ones and school staff about how to
    be ready to respond if anaphylaxis occurs.
  oStudents: Worksheets, backgrounders and presentations designed to promote
    peer-to-peer education about anaphylaxis.
  oCommunity Members:  General anaphylaxis education materials to drive broad
    knowledge, including an overview of federal laws that protect students at
    increased risk for anaphylaxis.

About Get Schooled in Anaphylaxis: An Interactive Experience
The coast-to-coast tour will hit key cities across the nation including:

  oLos Angeles, Calif. – Del Amo Fashion Center – Oct. 19-20
  oDenver, Colo. – Park Meadows Mall – Oct. 22
  oBaltimore, Md. – Arundel Mills Mall – Oct. 25
  oChicago, Ill. – Orland Square Mall – Oct. 27-28
  oDallas, Texas – Grapevine Mills Mall – Oct. 31
  oHouston, Texas – The Houston Galleria – Nov. 2-3
  oOrlando, Fla. – The Florida Mall – Nov. 8
  oAtlanta, Ga. – Lenox Square Mall – Nov. 10
  oCharlotte, N.C. – Concord Mills – Nov. 13
  oPhiladelphia, Pa. – King of Prussia Mall – Nov. 16-17

For more information on the tour schedule visit www.Anaphylaxis101.com.

About Get Schooled in Anaphylaxis™^
The Get Schooled in Anaphylaxis™  initiative offers practical information to
educate the school community to help those at risk for life-threatening
allergic reactions avoid their triggers, recognize anaphylaxis signs and
symptoms and understand how to quickly get appropriate treatment and immediate
medical care when anaphylaxis occurs. Visit www.Anaphylaxis101.com to explore
how anaphylaxis can affect the entire school community and learn more about
life-threatening allergic reactions. You can also download practical tools,
learn more about Julie Bowen's family story and watch a public service
announcement (PSA) featuring the actress and sign up to receive news about
activities and events. Follow the Twitter handle @Anaphylaxis101 to get the
latest news about the initiative.

Get Schooled in Anaphylaxis brings together information from leading patient,
professional and advocacy organizations, each with the common goal of
improving anaphylaxis education, and makes them accessible through
www.Anaphylaxis101.com.

About Anaphylaxis
Anaphylaxis is a life-threatening allergic reaction that can occur when the
body is exposed to an allergen. Anaphylaxis causes an estimated 1,500 deaths
each year. The prevalence of food allergies among children is on the rise,
now affecting one in 13 U.S. children.

Children and adolescents are among those most at-risk for anaphylaxis due to
increased exposure to potential allergic triggers. Symptoms may include
trouble breathing, chest pain, skin hives or redness of the skin, tightness in
the throat, swelling of the lips and/or tongue, nausea, dizziness, a decrease
in blood pressure and/or fainting. ^

Anaphylaxis symptoms may progress rapidly and become life-threatening,
requiring prompt recognition and treatment initiation. While avoidance of
allergic triggers is the critical first step in managing life-threatening
allergies, allergens are not always obvious and accidental exposure may still
happen.

Food allergy guidelines developed by National Institute of Allergy and
Infectious Diseases (NIAID), a division of the National Institutes of Health
(NIH), recommend epinephrine as the only first-line treatment for anaphylaxis
management and that it be available at all times to those at risk for
anaphylaxis. If experiencing anaphylaxis, a person should use an epinephrine
auto-injector and seek immediate emergency medical attention. ^

About Mylan Specialty
Mylan Specialty, a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty
pharmaceutical company focused on the development, manufacturing and marketing
of prescription drug products for the treatment of respiratory diseases,
life-threatening allergic reactions and psychiatric disorders. For more
information, please visit www.mylanspecialty.com.

About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in
health care. Working together around the world to provide seven billion
people access to high quality medicine, we innovate to satisfy unmet needs;
make reliability and service a habit, do what's right, not what's easy and
impact the future through passionate global leadership. We offer a growing
portfolio of more than 1,100 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral therapies,
upon which approximately one-third of HIV/AIDS patients in developing
countries depend. We also operate one of the largest active pharmaceutical
ingredient manufacturers and currently market products in approximately 150
countries and territories. Our workforce of more than 18,000 people is
dedicated to improving the customer experience and increasing pharmaceutical
access to consumers around the world. But don't take our word for it. See
for yourself. See inside. Mylan.com.

Get Schooled in Anaphylaxis™ is sponsored by and a trademark of Mylan
Specialty L.P.  © 2012. All rights reserved. MYS12-8088

SOURCE Mylan, Inc.

Contact: Nina Devlin, +1-724-514-1968 or Lauren Kashtan, +1-908-542-2600
 
Press spacebar to pause and continue. Press esc to stop.